SLD

Standard Land Development and M.J Newell Homes Aim to Expand Homeownership

Retrieved on: 
Monday, February 13, 2023
Growth, Organization, Marketing, Craig Miller (CEO), Maintenance, SLD, Newell, Housing, Real estate

LaBelle, Florida--(Newsfile Corp. - February 13, 2023) - Standard Land Development (SLD) and M.J. Newell Homes are working together to provide affordable housing options in Florida.

Key Points: 
  • LaBelle, Florida--(Newsfile Corp. - February 13, 2023) - Standard Land Development (SLD) and M.J. Newell Homes are working together to provide affordable housing options in Florida.
  • SLD handles land development, setting up the infrastructure like roads and utilities.
  • This approach has proven to be a huge success for SLD and M.J. Newell Homes, who have seen significant growth in the past five years.
  • The vision of SLD and M.J. Newell Homes is to provide high-quality living spaces at a price point that most income earners can afford.

Leidos Dynetics Team and Northrop Grumman to Collaborate on NASA Human Landing System Bid

Retrieved on: 
Wednesday, December 7, 2022
Blue Origin, Next Space Technologies for Exploration Partnerships, Dynetics, SLD, Partnership, Virginia Commercial Space Flight Authority, SpaceX, Science, Grumman, Annual report, Artemis program, International Space Station programme, Intelligence, International Space Station, Government, NASA, Habitation, HLS, Risk, Engineering, Northrop, Moon, Lunar Gateway, Communications satellite, Leidos

HUNTSVILLE, Ala., Dec. 7, 2022 /PRNewswire/ --Dynetics, a wholly-owned subsidiary of Leidos, today announced it has submitted a bid on the Human Landing System (HLS) Sustaining Lunar Development (SLD) contract for NASA's Artemis Mission.

Key Points: 
  • HUNTSVILLE, Ala., Dec. 7, 2022 /PRNewswire/ --Dynetics, a wholly-owned subsidiary of Leidos, today announced it has submitted a bid on the Human Landing System (HLS) Sustaining Lunar Development (SLD) contract for NASA's Artemis Mission.
  • Northrop Grumman will join the Dynetics team in this pursuit.
  • "We're excited to enter the competition to support NASA's Sustaining Lunar Development efforts, adding Northrop Grumman to our team," said Leidos Dynetics Group President Steve Cook.
  • Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $13.7 billion for the fiscal year ended December 31, 2021.

Freename x Calimero partnership: The potential of Web3 Naming & Private shards

Retrieved on: 
Monday, November 7, 2022
GLOBE, CET, AMA, TLD, SLD, Privacy, NFT, Blockchain, Non-fungible token, NEAR, Top-level domain, Communication, Domain, Internet service provider, Online shopping, Cryptocurrency, Calimero

Lets introduce you to these two Web3 revolutionaries:

Key Points: 
  • Lets introduce you to these two Web3 revolutionaries:
    Freename is the leading Web3 TLDs and Domains platform where users can register and mint their own customized Web3 TLDs.
  • Furthermore, on Freename, users can trademark their Web3 TLDs and Domains to protect their own Web3 Identity worldwide.
  • Freename and Calimero are joining forces by allowing customers to get directly on the Freename.io platform their NFT Domains registered on .calimero'' TLD.
  • And with an up and coming privacy-preserving project such as Calimero, the potential of owning a .calimero SLD is essentially limitless.

Istation instruction aligns to WIDA Prime V2 correlations for English learners

Retrieved on: 
Tuesday, October 4, 2022
Reading, Student, Educational technology, Learning, Certification, Multimedia, School, ELS, WIDA, Mathematics, CRA, Language development, English language, Environment, Language, Spanish language, Imagination, SLD, Tutoring, Online shopping, ISTAT

DALLAS, Oct. 4, 2022 /PRNewswire/ -- Istation, a leader in educational technology, has recently been WIDA PRIME V2 certified for instructional materials in reading and mathematics for pre-K through 8th grade. The PRIME V2 certification identifies how instructional materials correlate to the WIDA Standards Framework and how they connect to English and Spanish Language Development Standards. The certification also shows that the materials are relevant for both US and international educators to meet the academic needs of English learners (ELs).

Key Points: 
  • The PRIME V2 certification identifies how instructional materials correlate to the WIDA Standards Framework and how they connect to English and Spanish Language Development Standards.
  • The certification also shows that the materials are relevant for both US and international educators to meet the academic needs of English learners (ELs).
  • The WIDA PRIME V2 correlation process identifies how Istation's instruction and assessments meet specific standards, namely the 2012 Amplification of the English Language Development Standards (K12) and the Spanish Language Development (SLD) Standards (K12).
  • Istation Math and Reading support English learners through explicit, systematic and direct instruction in a personalized learning experience.

Precision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate for CAR T Relapsed Patient Population

Retrieved on: 
Wednesday, June 8, 2022
Oncology, Health, Genetics, Research, Science, Pharmaceutical, Biotechnology, DL2, GSI, Genome, Company, Anti-CD19 immunotoxin, Infection, Survival, B-cell maturation antigen, Multiple myeloma, Aggressive lymphoma, CT, Technology, Review, COVID-19, CRS, CD19, List, Cytokine release syndrome, Privacy, Intellectual property, Gene editing, ORR, Forward-looking statement, CAR, Investor, Neurotoxicity, DLBCL, Population, DL, CR, BCMA, SEC filing, Cell, SLD, ID, Patient, Precision, Compliance, SEC, Non-Hodgkin lymphoma, Private Securities Litigation Reform Act, Cohort, Achievement, Insurance, Program, Research, Society, Ownership, ASH, Disease, Encephalopathy, Toxicity, Nasdaq, Therapeutic index, FDA, Therapy, Growth, Clinical trial, Death, Safety, Pharmaceutical industry, Vaccine, New

The Company provided new clinical data and outlined the opportunity for its lead candidate, PBCAR0191, as a potential first-in-class allogeneic CD19 CAR T for the growing autologous CAR T relapsed patient population with aggressive lymphomas.

Key Points: 
  • The Company provided new clinical data and outlined the opportunity for its lead candidate, PBCAR0191, as a potential first-in-class allogeneic CD19 CAR T for the growing autologous CAR T relapsed patient population with aggressive lymphomas.
  • Most importantly, we are optimistic that, if approved, this could potentially help patients with aggressive lymphomas that relapse after CAR T treatment.
  • We believe this to be a first for allogeneic CAR T therapy studied in any population (earlier lines or more heavily pre-treated).
  • Precision will host a conference call and webcast today at 8:00 AM ET to review its ongoing allogeneic CAR T programs.

Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting

Retrieved on: 
Monday, June 6, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, DL2, Marketing, MAA, 1E9, Pneumonia, Company, Society, NHL, Graft-versus-host disease, EMA, Biologics license application, Common Terminology Criteria for Adverse Events, SLD, Food, Selinexor, Pharmacokinetics, Annual report, BLA, CAR, U.S. Securities and Exchange Commission, Regulation, Risk, FDA, ID, Transplant, Patient, Private Securities Litigation Reform Act, Lymphoid leukemia, Trial of the century, COVID-19, Infrared spectroscopy correlation table, SEC, CRS, European Medicines Agency, Regulation Fair Disclosure, Disclosure, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cancer, Safety, Pharmaceutical industry, Vaccine, Immunotherapy

+Safety assessment was performed using the Common Terminology Criteria for Adverse Events (v5) and the American Society for Transplantation and Cellular Therapy criteria.

Key Points: 
  • +Safety assessment was performed using the Common Terminology Criteria for Adverse Events (v5) and the American Society for Transplantation and Cellular Therapy criteria.
  • *One patient in DL 1 who received sLD developed COVID-19 pneumonia later died of complications of it, unrelated to ADI-001.
  • The Company expects to provide at least one additional clinical update for the ADI-001 Phase 1 study in the second half of 2022.
  • Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer.

ath Power Consulting Rebrands as apc and Announces New Offerings

Retrieved on: 
Wednesday, April 6, 2022
Well, Online, TD Bank, U.S. Army Corps of Engineers, Europe District, Organization, ROI, JPMorgan Chase, The Department, Bank of America, Multimedia, FAGE, Compliance, TAG Heuer, Capital One, Research, Social media, Idaho Department of Commerce, UX, Herms, Corps, Focus group, Bank, APC, SLD, TD, Solution, Commerce, Engineer, American Family Insurance, Public relations, Sales, Online shopping, CX, Porsche, Givenchy

BOSTON, April 6, 2022 /PRNewswire/ -- ath Power Consulting, a recognized leader in CX research and training, today unveiled their new brand identity. After more than two decades of people expressing difficulty with the pronunciation of the company name, as well as the desire for an image more representative of its capabilities, the firm (correctly pronounced "8th" Power Consulting) has officially rebranded.

Key Points: 
  • "The end-to-end engagement with our expert team is what truly distinguishes the experience clients enjoy when partnering with our firm.
  • We sought a brand image to visually represent that experience," stated apc President, Frank Aloi.
  • By formally shortening to apc, we provide consistency and ease of pronunciation, while also honoring our 25-year history".
  • "ath Power Consulting" remains the full name of the organization for legal purposes.

Stags Leap District Winegrowers Announces Esteemed Culinary Partners for Vineyard to Vintner, April 22-24, 2022

Retrieved on: 
Wednesday, February 23, 2022
Lisa Hammond (actress), The French Laundry, Woodhouse Chocolate, Stag's Leap Wine Cellars, Tasting room, NOLA, Laundry, Chimney Rock, Education, Association, Deer, Stags Leap, Farm, Stags' Leap Winery, Baldacci Family Vineyards, Stags Leap District AVA, Food, SLD, Meal, Wine, Michelin, Michelin Guide, Viticulture, Restaurant, Silverado Vineyards Winery, Quixote Winery

NAPA, Calif., Feb. 23, 2022 /PRNewswire-PRWeb/ --Offering even more reasons to attend its signature gathering, Stags Leap District Winegrowers today announced the roster of elite chefs and culinary partners for the 2022 Vineyard to Vintner weekend.

Key Points: 
  • NAPA, Calif., Feb. 23, 2022 /PRNewswire-PRWeb/ --Offering even more reasons to attend its signature gathering, Stags Leap District Winegrowers today announced the roster of elite chefs and culinary partners for the 2022 Vineyard to Vintner weekend.
  • "While renowned wines and rare library offerings take the spotlight throughout the weekend, guests will also be treated to an array of opulent menus designed to beautifully complement the power and grace of Stags Leap District varietals," said Nancy Bialek, Executive Director of Stags Leap District Winegrowers.
  • Vintners will showcase critically acclaimed wines as well as a sneak preview of the Stags Leap District 2019 Appellation Collection Cabernet Sauvignons, scheduled for release in October 2022.
  • To learn more about the Stags Leap District, please visit stagsleapdistrict.com or find the Association on Facebook.com/StagsLeapDistrict, Instagram.com/StagsLeapAVA and Twitter @StagsLeapAVA.

Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T Pipeline

Retrieved on: 
Saturday, December 11, 2021
Oncology, Health, Genetics, Research, Science, Pharmaceutical, Biotechnology, Therapy, Intellectual property, List, Infection, Population, Ownership, Lymphoma, CRS, Trial of the century, Compliance, Forward-looking statement, FDA, Precision, Therapeutic index, Growth, Associate professor, Safety, Program, ASH, CAR, Eld, Society, H. Lee Moffitt Cancer Center & Research Institute, Investor, NHL, B-cell maturation antigen, Cell, Genome, Nasdaq, COVID-19, Research institute, SEC, CD19, SLD, Research, Biotechnology, ID, Privacy, View, Company, Insurance, Private Securities Litigation Reform Act, Gene editing, Patient, Achievement, Technology, Pharmaceutical industry, Vaccine

Precisions clinical stage CAR T pipeline continues to generate promising data in lymphoma patients.

Key Points: 
  • Precisions clinical stage CAR T pipeline continues to generate promising data in lymphoma patients.
  • Flat doses of PBCAR19B CAR T cells following standard lymphodepletion (sLD)3 are administered starting at Dose Level 1 (2.7 108 CAR T cells).
  • Precision BioSciences CAR T cells are the only allogeneic CAR T cells in human clinical trials made with a single gene editing step designed to specifically avoid the potentially deleterious effects of making multiple edits to T cells.
  • Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS genome editing platform.

USAble Life Appoints Steve Valenti As Chief Revenue Officer

Retrieved on: 
Monday, November 8, 2021
Blue Cross Blue Shield Association, Blue Shield, View, Unum, Blue, Leadership, Johns Hopkins University, ROCK, Dental, Bachelor of Arts and Science, Multimedia, SLD, Supplement, Anthem, Blue Cross, Life, District, Health insurance, Management

LITTLE ROCK, Ark., Nov. 8, 2021 /PRNewswire/ --USAble Life, a leader in the field of ancillary insurance, today announced the appointment of Steve Valenti as chief revenue officer.

Key Points: 
  • LITTLE ROCK, Ark., Nov. 8, 2021 /PRNewswire/ --USAble Life, a leader in the field of ancillary insurance, today announced the appointment of Steve Valenti as chief revenue officer.
  • Steve will also oversee the Supplemental, Life, Disability (SLD), and Dental sales for group and individual products.
  • Before coming to USAble Life, Steve was vice president, specialty distribution, with Anthem in Ohio.
  • USAble Life products are licensed to sell in 49 states and the District of Columbia.USAble Life maintains an "A" excellent rating from A.M. Best.